Insight into the Pharmaceutical Industry

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Drug design and testing,. Drug Names Chemical name- describes its molecular structure and distinguishes it from other drugs.
Drug Development Marilyn Lockyer, RN, BSc, CCRP Senior Clinical Research Coordinator King Faisal Heart Institute Marilyn Lockyer, RN, BSc, CCRP Senior.
Phase I metabolism may either detoxify or toxify. Phase I reactions produce a more polar molecule that is easier to eliminate. Phase I reactions can sometimes.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Chapter 15 NATURE AND NURTURE. You Started as One Cell: Stem cells.
Nanotechnology in Drug Discovery- Development and Delivery
What Do Toxicologists Do?
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Stefan Franzén Introduction to clinical trials.
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
Drug Discovery and Development
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Stages of drug development
Drug discovery and development
Drug Discovery and Development How are drugs discovered and developed?
Development of a drug Based on: a known active drug known receptor known endogenous ligand Of natural origin: microorganisms Plants Animals.
Structure-Activity-Relationships (SAR’s) Once a lead has been discovered, it is important to understand precisely which structural features are responsible.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Stefan Franzén Introduction to clinical trials.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Drug Discovery and Development How are drugs discovered and developed?
1 Intellectual Property in the Innovative Pharmaceutical Industry *** June 12, 2006 Gregg C. Benson Assistant General Counsel – Intellectual Property 1.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
Drug Discovery and Development How are drugs discovered and developed?
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Concepts and Applications of Pharmacokinetics
It is necessary to have a quick assay for the desired biological activity and to be able to separate the bioactive compound from the other inactive substances.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
PHARMACEUTICS- IV (PHT 414 ) Dr. Mohammad Khalid Anwer SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L111/16/2016.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Shows tendency for mergers. These big companies may be shrinking – much research is now outsourced to low cost countries like Latvia, India, China and.
Molecular Modeling in Drug Discovery: an Overview
독성학 박 대 훈 한약재산업학과
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
The process of drug development. Drug development 0,8 – 1 mld. USD.
Clinical Trials.
FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.
Pharmacology I Session One Pharmacological Principles.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Difference to Generics What can they do for us in the future
The Stages of a Clinical Trial
Drug Discovery &Development
Clinical Trials — A Closer Look
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Discovery and Development of Medicines
An Introduction to Medicinal Chemistry 3/e
Biopharmaceutics Dr Mohammad Issa Saleh.
Drug design and testing,
Drug Development Stages
Pharmacologic Principles – Chapter 2
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Basic Pharmacology slideworld. org/slideshow
Drug and Drug Products Quality & Testing
Xenobiotic or Drug Metabolism
Drug Design and Drug Discovery
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Clinical Pharmacokinetics
Objective 2 Biomedical Research Methods
Pharmaceuticals Industry
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Presentation transcript:

Insight into the Pharmaceutical Industry How are drugs discovered and developed?

Global Pharmaceuticals

Areas of focus

The process R&D c20% Marketing/Sales c30%

Patenting Patents protect drugs from copycat versions for 20 years after the drug is invented. This is a bitter pill for pharmaceutical companies because it can take eight years or more after invention to accumulate enough data to get a drug past the U.S. Food and Drug Administration.

Choosing a Disease

Identifying a Drug Target Drug Target = specific macromolecule, or biological system, which the drug will interact with Sometimes this can happen through incidental observation…

Finding the Lead Compound Screening Natural Products Screening synthetic banks “Lead compound” = structure that has some activity against the chosen target, but not yet good enough to be the drug itself. If not known, determine the structure of the “lead compound”

Structure-Activity-Relationships (SAR’s) Which structural features are responsible for its biological activity (i.e. to identify the“pharmacophore”) Pharmacophore = the structural features directly responsible for activity Optimize structure to improve interactions with target

Computer aided drug design If one knows the precise molecular structure of the target (enzyme or receptor), then one can use a computer to design a perfectly-fitting ligand. Drawbacks: Most commercially available programs do not allow conformational movement in the target (as the ligand is being designed and/or docked into the active site). Thus, most programs are somewhat inaccurate representations of reality.

Choosing the Bioassay bioassay = A test used to determine biological activity In vitro: In an artificial environment, as in a test tube or culture media In vivo: In the living body, referring to tests conducted in living animals.

Toxicity Toxicity standards are continually becoming tougher Must use in vivo (i.e. animal) testing to screen for toxicity Each animal is slightly different, with different metabolic systems, etc. Thus a drug may be toxic to one species and not to another

Metabolism of Drugs The body regards drugs as foreign substances, not produced naturally. Sometimes such substances are referred to as “xenobiotics” Body has “goal” of removing such xenobiotics from system by excretion in the urine The kidney is set up to allow polar substances to escape in the urine, so the body tries to chemically transform the drugs into more polar structures.

PKPD Pharmacodynamics explores what a drug does to the body, whereas pharmacokinetics explores what the body does to the drug.

ADME ADME stands for absorption, distribution, metabolism, and excretion

Manufacture of Drugs Pharmaceutical companies must make a profit to continue to exist Therefore, drugs must be sold at a profit One must have readily available, inexpensive starting materials One must have an efficient synthetic route to the compound As few steps as possible Inexpensive reagents

The route must be suitable to the “scale up” needed for the production of at least tens of kilograms of final product This may limit the structural complexity and/or ultimate size (i.e. mw) of the final product In some cases, it may be useful to design microbial processes which produce highly functional, advanced intermediates. This type of process usually is more efficient than trying to prepare the same intermediate using synthetic methodology.

Clinical Trials Pre-clinical: animals Phase I: Drug is tested on healthy volunteers to determine toxicity relative to dose and to screen for unexpected side effects Phase II: Drug is tested on small group of patients to see if drug has any beneficial effect and to determine the dose level needed for this effect Phase III: Drug is tested on much larger group of patients and compared with existing treatments and with a placebo

FDA approval

Post patent expiration Generic drugs are copies of brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and strength as the original drug. In other words, their pharmacological effects are exactly the same as those of their brand-name counterparts